相关实验视频
Updated: Jun 22, 2025

10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.7K
癌症住院患者的脱节过程
1PIH Health Whittier Hospital, Clinical Nurse Specialist, Medical Oncology, Whittier, CA.
Seminars in oncology nursing
|June 30, 2024
概括
与医院相关的脱条件 (HAD) 显著影响癌症患者. 促进早期流动性和跨学科合作是防止HAD及其严重后果的关键.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 康复医学 康复医学 康复医学
背景情况:
- 与医院相关的退化 (HAD) 是住院患者,特别是癌症患者的一个重大问题.
- 癌症患者因其诊断和治疗副作用的性质而对HAD具有独特的脆弱性.
研究的目的:
- 为癌症患者提供与医院相关的脱条件的概述.
- 为了确定这一群体中HAD的风险因素,轨迹和后果.
- 讨论跨学科的角色,最佳实践,以及预防HAD的护理影响.
主要方法:
- 使用PubMed和谷歌学者进行了全面的文献搜索.
- 关键词包括"医院*", "移动性"",不移动性"",脱"",癌症"和"瘤学".
- 分析了同行评审的研究,评论文章和专业组织的指导方针.
主要成果:
- 综合了38个参考文献,突出了HAD作为一个具有严重后果的广泛问题.
- 身体活动和标准化的移动性评估对于预防HAD至关重要.
- 跨学科的合作对于有效的HAD预防策略至关重要.
结论:
- 改善住院癌症患者的流动性对于减轻HAD并发症至关重要.
- 护士在评估流动性,识别风险和实施干预方面发挥着关键作用.
- 诸如人员短缺和高工作负载等障碍,可能会阻碍护士促进流动性的能力.
相关概念视频
Classical Conditioning in Daily Life
715
Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
715
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
Restorative Care
1.9K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
1.9K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192
Decreased Body Temperature
605
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
605

